Effects of BW A868C, a selective prostaglandin DP receptor antagonist, in dog isolated vascular preparations
- 15 May 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 303 (3) , 187-192
- https://doi.org/10.1016/0014-2999(96)00037-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- In vitro characterization of prostanoid receptors on human myometrium at term pregnancyBritish Journal of Pharmacology, 1993
- Further studies on ocular responses to DP receptor stimulationEuropean Journal of Pharmacology, 1993
- In vitro characterization of prostanoid FP‐, DP‐, IP‐ and TP‐receptors on the non‐pregnant human myometriumBritish Journal of Pharmacology, 1992
- The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonistBritish Journal of Pharmacology, 1989
- Further analysis of anomalous pKB values for histamine H2‐receptor antagonists on the mouse isolated stomach assayBritish Journal of Pharmacology, 1985
- Prostanoid receptors — the development of a working classificationTrends in Pharmacological Sciences, 1984
- Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogueProstaglandins, 1983
- Pharmacological and cardiovascular properties of a hydantoin derivative, BW 245 C, with high affinity and selectivity for PGD2 receptorsProstaglandins, 1983
- Studies of the characterisation of prostanoid receptors: A proposed classificationProstaglandins, 1982